Safi Biotherapeutics is an early stage Boston-area biotechnology company developing cell therapeutics and products from human hematopoietic progenitor sources.

EdenRoc is a private equity-backed holding/operating company managing life science/pharmaceutical startup companies including Metro International Biotech, ArcBio, Dovetail Genomics, Liberty Biosecurity, Claret Bioscience and several other companies still in stealth mode. Manage operational and financial success with full profit and loss (P&L) responsibility of 8 bioscience/pharmaceutical startup companies from Harvard, Stanford, Cornell, Washington University and University of California – Santa Cruz. Oversee strategic planning in addition to budgeting, financial management, contracts, human resources, procurement, compliance, real estate, facilities, information technology and risk management through combined roles of chief administrative officer (CAO), chief financial officer (CFO) and chief operating officer (COO). Deliver leadership from proof of concept to commercial and clinical stages of development to ensure market share growth and profitability.- Raised 4 funding rounds managing an annual budget of $45M.- Partnered with 3 first-time CEOs and delivered employee and contractor growth from 17 to 98 throughout 4 countries.- Negotiated numerous technology licenses, real estate leases/subleases and clinical trial agreements; continually ensure current good manufacturing practice (cGMP) to guarantee growth and profitability.

Mentor to some phenomenal teams.

De la femme is a start-up social entrepreneurial non-profit that focuses on young women who have received a post-bachelors degree (25-35) and who are either just entering the workforce or are interested in moving into a second or third job for upward career momentum.

Recruited back to the company to initiate and manage a portfolio of inventions, patent filings and corporate-sponsored research initiatives throughout numerous hospital departments and specialty facilities. Developed the strategy to optimize commercial impact, economic returns and cost savings of key and emerging discoveries, innovations and other technological capabilities to deliver high value commercial outcomes. Identified, assessed, organized, characterized and marketed patient-benefiting and cost-saving technologies. Licensed technological expertise, research information, intellectual property, patents and software to industry and external partners. Collaborated as part of a multidisciplinary team assembled to give special emphasis to areas of institutional excellence and high market potential. Ensured compliance with departments including the Clinical Trials Office, Office of Industry Interaction, Transactional Affairs, and Supply Chain. Delivered internal training on various programs to maximize support and success. - Directed over 190 inventions, 220 patent filings and license & research agreements with companies including Novo Nordisk, Merck, GSK, Questcor, Beckman Coulter and OvaScience during role.- Delivered advisory guidance to licensees by assisting on steering committees.

Mascoma is a leader in advanced bioconversion products by developing and delivering innovative technologies for manufacturing companies that are focused on the conversion of abundant biomass to replace petroleum-based products. At the time, it was a cellulosic ethanol biofuels startup funded by Kosla, Flagship, Vantage Point, General Catalyst, KPCB, Atlas, Pinnacle, GM, and Marathon Oil.Served as liaison across business, biology, and engineering to deliver communication between departments and certify the resulting impact of growth. Led a third party public relations firm and authored content for the corporate website. Managed redesign and messaging of both website and fundraising presentations. Collaborated with scientists and engineers through innovative thinking, brainstorming, and project management sessions and delivered training seminars to ensure support. Created and maintained competitive intelligence procedures, database, innovative internal programs and blog to deliver market share growth and profitability in alignment with corporate goals.- Recruited as the 5th “business” employee and 20th overall in this cellulosic ethanol biofuels startup.- Delivered over $100M in investments by authoring or editing investor presentations and due diligence documents. - Aided company growth to 125 employees in 3 states through training and development.- Generated over 180 innovative ideas that led to the filing of 40 distinct patents.- Led the implementation of E-Notebook, a computer program designed to document research, experiments and procedures and improve productivity.

UniQuest Pty Ltd. is the technology and consulting arm of the University of Queensland. The Company helps create spin-off companies based on the results of research conducted at the University.Evaluated, developed and executed the commercial strategy for technologies developed by University researchers. Delivered feasibility assessments, intellectual property (IP) strategy, financial valuation, research planning, corporate foundation and fundraising, management recruitment and overall project management. Led 4 project teams, partnered as co-lead on 5 projects and recruited outside consultants and management, where appropriate, to deliver results in alignment with University directives.- Served on the scientific steering committee of a $15M research and licensing program with CSR Sugar Pty Ltd in its efforts to develop genetically modified sugarcane.- Led the creation and/or funding of TenasiTech Pty Ltd polymer products, Pepfactants Pty Ltd industrial emulsions and Progel Pty Ltd microencapsulation technology.

Managed all agreements and invention disclosures from 10 departments within the Department of Medicine, representing 40% of the area served by the hospital. Mentored junior staff members to boost faculty approval.- Executed license/option agreements with 3 faculty startups and over 150 inventions.

CRI’s mission is to pair solution-oriented research with real-world needs for the enrichment of society through the protection, acceleration, and commercialization of Northeastern innovation.Assessed new invention disclosures in all research areas of the University. Developed and implemented new filing and docketing system for intellectual property and agreements.- Reduced turnaround time for sponsored research agreements from average of 2 months to an average of 2 weeks; negotiated terms of nearly 50 sponsored research agreements in less than a year.- Reduced patent expenditures by 50% while maintaining the same number of filings

ARTI is a private, not-for-profit agent for IU, charged with increasing the university's collaboration with the private sector. The group assists entrepreneurs with business formation, development and maturation by providing facilities, amenities, support and networking opportunities.Performed all due diligence, prior-art searches, market analysis, license strategy development, and managed outside legal counsel for over 70 technologies for the College of Science and Medical and Dental Schools. Performed valuation and negotiated terms for a $6M license agreement for a research tool. - Founded Indiana Labs LLC, an internal startup company, to seek Small Business Innovation Research (SBIR) funding for value-added pre-clinical research.- Developed active commercial interest in 22 of 35 available technologies in a 10-month period by creating marketing summaries and prospecting potential investors.- Delivered FDA regulatory aid to the group as needed based on extensive experience.

The Barbara Ann Karmanos Cancer Institute is the largest cancer research and provider network in Michigan and is affiliated with the Wayne State University School of Medicine.Created investor materials for project fundraising and investor updates and finalized all investment contracts. Evaluated new technologies for potential inclusion in new oncology-focused venture. - Secured $9M from 14 angel investors for what is now Delphinus Medical Technologies.- Successfully eliminated budget overrun by almost $3M and reduced time to completion by 12 months through partnership with a national laboratory contractor during role as Project Manager for a newly formed medical device development venture.- Collaboratively negotiated and secured a license agreement for jointly held intellectual property, receiving over $6M in cash and equity and avoiding a potential patent interference.- Founded and became Vice President of SciTech Development LLC, an internal startup company created on behalf of the company, to assist a Small Business Innovation Research (SBIR) pre-clinical drug development company that was awarded several SBIR government grants.